Eliana Barrenho : Citation Profile


Are you Eliana Barrenho?

Organisation de Coopération et de Développement Économiques (OCDE) (50% share)
Imperial College (50% share)

2

H index

0

i10 index

13

Citations

RESEARCH PRODUCTION:

1

Articles

2

Papers

RESEARCH ACTIVITY:

   6 years (2013 - 2019). See details.
   Cites by year: 2
   Journals where Eliana Barrenho has often published
   Relations with other researchers
   Recent citing documents: 5.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pba885
   Updated: 2024-11-04    RAS profile: 2024-06-09    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Miraldo, Marisa (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Eliana Barrenho.

Is cited by:

Gamba, Simona (3)

Miraldo, Marisa (3)

Pertile, Paolo (2)

Magazzini, Laura (2)

Toulemon, Lea (2)

Rasul, Imran (2)

de Paula, Aureo (2)

Qadimi Rabbani, Maysam (1)

Rabbani, Maysam (1)

Florio, Massimo (1)

Hollis, Aidan (1)

Cites to:

DiMasi, Joseph (3)

Zenou, Yves (3)

Erreygers, Guido (3)

Acemoglu, Daron (3)

Lee, Lung-Fei (3)

Nicholson, Sean (2)

Molitor, David (2)

Chaney, Thomas (2)

Roediger-Schluga, Thomas (2)

bloom, nicholas (2)

Pammolli, Fabio (2)

Main data


Where Eliana Barrenho has published?


Recent works citing Eliana Barrenho (2024 and 2023)


YearTitle of citing document
2023.

Full description at Econpapers || Download paper

2023A note on disease burden and pharmaceutical R&D. (2023). Nabin, Munirul ; Mohan, Vijay. In: Australian Economic Papers. RePEc:bla:ausecp:v:62:y:2023:i:4:p:633-649.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023The role of patient organisations in research and development: Evidence from rare diseases. (2023). Miraldo, Marisa ; Gentilini, Arianna. In: Social Science & Medicine. RePEc:eee:socmed:v:338:y:2023:i:c:s0277953623006895.

Full description at Econpapers || Download paper

2024Many are called, few are chosen: the role of science in drug development decisions. (2024). Belderbos, Rene ; Kelchtermans, Stijn ; Leten, Bart ; Colen, Linde. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:49:y:2024:i:2:d:10.1007_s10961-022-09982-6.

Full description at Econpapers || Download paper

Works by Eliana Barrenho:


YearTitleTypeCited
2013The determinants of attrition in drug development: a duration analysis In: Working Papers.
[Full Text][Citation analysis]
paper2
2019Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries In: Health Economics.
[Full Text][Citation analysis]
article9
2019Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS In: Health, Econometrics and Data Group (HEDG) Working Papers.
[Full Text][Citation analysis]
paper2

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team